ResearcherKAN Research InstituteActive in the last 2 years
Akihito Machinaga
Matched on ORCID iD 0009-0001-9552-8806; OpenAlex author ID A5048770852. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 6
- FRET imaging of ERK activity in an orthotopic xenograft model of patient-derived pancreatic ductal adenocarcinoma using imaging window. Co-author DOI 10.1242/jcs.265075↗
- Quantitative Live Imaging Reveals Phase Dependency of PDAC Patient-Derived Organoids on ERK and AMPK Activity. Co-author DOI 10.1111/cas.16439↗
- Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models. Last author DOI 10.1038/s41467-024-46167-1↗
- Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41556-024-01498-5↗
- Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase. Co-author DOI 10.1186/s12935-023-02928-4↗
- Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients. Co-author DOI 10.1097/mpa.0000000000001438↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroshi Seno · 3 shared papers, 2024–2026 · strength 0.67
- Paper FRET imaging of ERK activity in an orthotopic xenograft model of patient-derived pancreatic ductal adenocarcinoma using… DOI 10.1242/jcs.265075↗
- Paper Quantitative Live Imaging Reveals Phase Dependency of PDAC Patient-Derived Organoids on ERK and AMPK Activity. DOI 10.1111/cas.16439↗
- Paper Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. DOI 10.1038/s41556-024-01498-5↗
- Toru Hiratsuka · 2 shared papers, 2025–2026 · strength 0.52
- Yuzo Kodama · 2 shared papers, 2023–2024 · strength 0.36
- Paper Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the c… DOI 10.1186/s12935-023-02928-4↗
- Paper Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. DOI 10.1038/s41556-024-01498-5↗
- Houssam Al-Koussa · 1 shared paper, 2026 · strength 0.27
- Ken Sasai · 2 shared papers, 2019–2024 · strength 0.25
- Paper Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. DOI 10.1038/s41556-024-01498-5↗
- Paper Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001438↗
- Shoko Tsukamoto · 1 shared paper, 2025 · strength 0.25
- Kohei Yamakawa · 1 shared paper, 2023 · strength 0.20
- Takashi Aoi · 1 shared paper, 2023 · strength 0.20
- Shuntaro Tsukamoto · 1 shared paper, 2024 · strength 0.17
- Youya Nakazawa · 1 shared paper, 2024 · strength 0.17
- Eisuke Iwasaki · 1 shared paper, 2024 · strength 0.15
- Toshiro Sato · 1 shared paper, 2024 · strength 0.15
- Takanori Kanai∥ · 1 shared paper, 2024 · strength 0.15
- Hiroki Tamagawa · 1 shared paper, 2024 · strength 0.15
- Minoru Kitago · 1 shared paper, 2024 · strength 0.15
- Yuko Kitagawa · 1 shared paper, 2024 · strength 0.15
- Yuichi Hori · 1 shared paper, 2019 · strength 0.10
- Kazuya Shimizu · 1 shared paper, 2019 · strength 0.10
- Tomoo Itoh · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.